Search

Your search keyword '"Ning Shao"' showing total 953 results

Search Constraints

Start Over You searched for: Author "Ning Shao" Remove constraint Author: "Ning Shao"
953 results on '"Ning Shao"'

Search Results

1. Dihydrofolate reductase-like protein inactivates hemiaminal pharmacophore for self-resistance in safracin biosynthesis

2. Improved Temporal Fuzzy Reasoning Spiking Neural P Systems for Power System Fault Diagnosis

3. A Bidirectional Single‐Cell Migration and Retrieval Chip for Quantitative Study of Dendritic Cell Migration

4. Effective and biocompatible antibacterial surfaces via facile synthesis and surface modification of peptide polymers

5. Addressing MRSA infection and antibacterial resistance with peptoid polymers

6. A Wide-Area Measurement System-Based Load Encroachment Identification Method Applicable to Power Systems with High Wind Power Penetration

7. Novel Faulted-Section Location Method for Active Distribution Networks of New-Type Power Systems

8. Convenient and Controllable Synthesis of Poly(2-oxazoline)-Conjugated Doxorubicin for Regulating Anti-Tumor Selectivity

9. Development and validation of a novel immunotype for prediction of overall survival in patients with clear cell renal cell carcinoma

10. Clinical characteristics of 14 COVID-19 deaths in Tianmen, China: a single-center retrospective study

11. Microbial Metabolite Inspired β‐Peptide Polymers Displaying Potent and Selective Antifungal Activity

12. HIF-1α contributes to Ang II-induced inflammatory cytokine production in podocytes

13. Fault Diagnosis Method of Intelligent Substation Protection System Based on Gradient Boosting Decision Tree

14. State Evaluation and Fault Prediction of Protection System Equipment Based on Digital Twin Technology

15. Identification of seven long noncoding RNAs signature for prediction of biochemical recurrence in prostate cancer

16. Evaluation of Single-Cell Cytokine Secretion and Cell-Cell Interactions with a Hierarchical Loading Microwell Chip

17. Modification of American Joint Committee on cancer prognostic groups for renal cell carcinoma

18. miR-221-5p enhances cell proliferation and metastasis through post-transcriptional regulation of SOCS1 in human prostate cancer

19. A novel gene signature to predict immune infiltration and outcome in patients with prostate cancer

20. Causes of Death and Conditional Survival of Renal Cell Carcinoma

22. The Expression and Significance of NLRP3 Inflammasome in Patients with Primary Glomerular Diseases

23. Exenatide Delays the Progression of Nonalcoholic Fatty Liver Disease in C57BL/6 Mice, Which May Involve Inhibition of the NLRP3 Inflammasome through the Mitophagy Pathway

25. Relationship between Oxidant/Antioxidant Markers and Severity of Microalbuminuria in the Early Stage of Nephropathy in Type 2 Diabetic Patients

29. Immunogenicity and safety of an ORF7-deficient skin-attenuated and neuro-attenuated live vaccine for varicella: a randomised, double-blind, controlled, phase 2a trial

33. Head-to-head immunogenicity comparison of an Escherichia coli-produced 9-valent human papillomavirus vaccine and Gardasil 9 in women aged 18–26 years in China: a randomised blinded clinical trial

34. Immunogenicity and safety of an Escherichia coli-produced human papillomavirus (types 6/11/16/18/31/33/45/52/58) L1 virus-like-particle vaccine: a phase 2 double-blind, randomized, controlled trial

38. Safety and immunogenicity of an Escherichia coli-produced 9-valent human papillomavirus L1 virus-like particle vaccine (types 6/11/16/18/31/33/45/52/58) in healthy adults: an open-label, dose-escalation phase 1 clinical trial

39. Safety and immunogenicity of a skin- and neuro-attenuated live vaccine for varicella: a randomized, double-blind, controlled, dose-escalation and age de-escalation phase 1 clinical trial

40. Efficacy, safety, and immunogenicity of an Escherichia coli-produced Human Papillomavirus (16 and 18) L1 virus-like-particle vaccine: end-of-study analysis of a phase 3, double-blind, randomised, controlled trial

41. Safety and immunogenicity of a live-attenuated influenza virus vector-based intranasal SARS-CoV-2 vaccine in adults: randomised, double-blind, placebo-controlled, phase 1 and 2 trials

49. Analysis of monoclonal antibodies to establish a universal IVRP method suitable for identifying quadrivalent HPV vaccines that can replace in vivo efficacy tests

Catalog

Books, media, physical & digital resources